title: Does prior treatment with fumaric acid esters predispose to tuberculosis in patients on etanercept?
authors.forename: K
authors.initials: K
authors.lastname: Ahmad
authors.forename: T J
authors.initials: TJ
authors.lastname: McDonnell
authors.forename: S
authors.initials: S
authors.lastname: Rogers
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D004198:Disease Susceptibility; D004338:Drug Combinations; D000068800:Etanercept; D005650:Fumarates / Q000009:adverse effects*; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008297:Male; D011565:Psoriasis / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor; D016896:Treatment Outcome; D014374:Tuberculin Test; D014388:Tuberculosis, Lymph Node / Q000139:chemically induced*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D005650:Fumarates; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept